INFECÇÕES NOSOCOMIAIS POR KLEBISIELLA PNEUMONIAE PRODUTORA DE KPC EM HOSPITAL TERCIÁRIO DE SALVADOR

Fernanda Nunes Passos(Hospital São Rafael), Paulo Benígno Pena Batista(D’Or Institute for Research and Education), Andre Luiz Gobatto(Hospital São Rafael), Rogério da Hora Passos(Yahoo (Spain)), Marcio Oliveira Silva(Hospital São Rafael), Suzete Nascimento da Guarda(Hospital São Rafael), Juliana Caldas(Escola Bahiana de Medicina e Saúde Pública), Maria Goreth Matos de A. Barberino(Hospital São Rafael), Lis Moreno De Oliveira Kalid(Hospital São Rafael), Camila Araujo de Lourenzo Barcia, Clara Sá Macedo Dantas(Hospital São Rafael), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), João Gabriel Rosa Ramos(D’Or Institute for Research and Education)
The Brazilian Journal of Infectious Diseases
December 1, 2018
10.1016/j.bjid.2018.10.089
Cited by 0

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
|The Lancet|2022|467
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
|Emerging infectious diseases|2021|215
Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial
|Biomedicine & Pharmacotherapy|2021|121